ID   DM150/B7-8
AC   CVCL_ZL68
DR   Wikidata; Q98125883
RX   PubMed=7703289;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4932; HLA-B (Note=Allele B*07).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F869 ! DM150
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
RX   PubMed=7703289; DOI=10.1089/hum.1995.6.1-87;
RA   Fenton, Robert T.
RA   Sznol, Mario
RA   Luster, Douglas G.
RA   Taub, Dennis Daniel
RA   Longo, Dan Louis
RT   "A phase I trial of B7-transfected or parental lethally irradiated
RT   allogeneic melanoma cell lines to induce cell-mediated immunity
RT   against tumor-associated antigen presented by HLA-A2 or HLA-A1 in
RT   patients with stage IV melanoma. NCI protocol T93-0161. BRMP protocol
RT   9401.";
RL   Hum. Gene Ther. 6:87-106(1995).
//